BioCryst Pharma (BCRX) Will Make Late-Breaker Presentation on Galidesivir Study in ZIKV-Infected Monkeys
Tweet Send to a Friend
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that results from a study of galidesivir (formerly BCX4430) administered to Rhesus monkeys infected ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
